MEI Pharma buys $100 million of Litecoin as treasury asset, with Charlie Lee and GSR as lead investors
Quick Take Nasdaq-listed MEI Pharma has bought 929,548 Litecoin (LTC) tokens following a recent $100 million private placement. The company becomes the first U.S.-listed firm to adopt LTC as its primary treasury asset.
MEI Pharma (ticker MEIP), a Nasdaq-listed pharmaceutical company, has acquired 929,548 Litecoin (LTC) tokens for $100 million, becoming the first U.S.-listed firm to adopt Litecoin as its primary treasury reserve asset.
The tokens were purchased at an average price of $107.58 between July 30 and Aug. 4. At current market prices of around $124, the LTC treasury is now valued at about $115 million. Litecoin is currently the 24th-largest cryptocurrency by market capitalization, with a total market cap of about $9.5 billion, according to The Block’s Litecoin price page.
The purchase was fully funded through a $100 million private placement closed last month, with Litecoin creator Charlie Lee and crypto trading firm GSR acting as lead investors. Lee has joined MEI’s board of directors, replacing Taheer Datoo, and GSR has been appointed as the company’s treasury asset manager. Other investors include the Litecoin Foundation, ParaFi, Hivemind, Primitive, RLH Capital, and Delta Blockchain.
MEI said its treasury strategy focuses on Litecoin due to its 13-year record of uninterrupted uptime, low fees, and fast settlement. The company also cited Litecoin’s integration into platforms like BitPay, PayPal, and Robinhood as validation of its utility.
The company may expand the strategy to include Litecoin mining and other initiatives. MEI continues to operate its drug development pipeline, including voruciclib, an experimental treatment being developed for cancer, and anticipates commencing further investigational research and development in the next several months.
Titan Partners Group, a division of American Capital Partners, acted as the sole placement agent for the deal. Legal advisors were Morgan, Lewis & Bockius LLP for MEI and Lucosky Brookman LLP for the placement agent.
MEI joins a growing number of public companies adopting crypto treasury strategies. While Strategy (formerly MicroStrategy) has led the way with bitcoin, other firms have recently added Ethereum , Solana , XRP , Dogecoin , SUI , Toncoin , and other tokens to their balance sheets.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Mars Morning News | ZCash shielded pool assets reach 23% of total supply, network usage surges
The potential end of the U.S. government shutdown means the SEC and CFTC will resume crypto regulatory work. The SEC may prioritize support for tokenization businesses, while the CFTC plans to promote spot crypto trading. The Hello 402 contract has been exposed to risks of unlimited issuance and centralized manipulation. The probability of a Fed rate cut in December is 69.6%. Summary generated by Mars AI. The accuracy and completeness of this summary are still being iteratively updated by the Mars AI model.

The Federal Reserve pours cold water, December rate cut expectations plummet!
San Francisco Federal Reserve President Daly, who has consistently supported interest rate cuts, also sent a cautious signal on Thursday. Market expectations have quickly reversed, with short-term interest rate futures now showing only a 55% probability of a Fed rate cut in December...

Has sector rotation in the crypto market really failed?
With BTC maturing first, ETH lagging behind, and SOL still needing time, where are we in the cycle?

Prospects of Ethereum Protocol Technical Upgrade (1): The Merge
This article will interpret the first part of the roadmap (The Merge), explore what technical design improvements can still be made to PoS (Proof of Stake), and discuss ways to implement these improvements.

